Albertsons Companies (ACI)
NYSE:ACI
ACI Stock Chart & Stats
$17.45
$0.02(0.10%)
At close: 4:00 PM EST
$17.45
$0.02(0.10%)
Day’s Range― - ―
52-Week Range$15.80 - $22.90
Previous CloseN/A
Volume3.94M
Average Volume (3M)5.98M
Market Cap
$8.97B
Enterprise Value$24.82B
Total Cash (Recent Filing)$214.50M
Total Debt (Recent Filing)$15.43B
Price to Earnings (P/E)8.3
Beta0.10
Next Earnings
Apr 14, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend Yield3.49%
Share Statistics
EPS (TTM)0.72
Shares Outstanding513,913,150
10 Day Avg. Volume6,482,476
30 Day Avg. Volume5,981,217
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)3.52
Price to Sales (P/S)0.15
P/FCF Ratio15.91
Enterprise Value/Market Cap2.77
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit1.12
Enterprise Value/Ebitda5.99
Forecast
1Y Price Target
$20.75Price Target Upside18.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)2.27
Revenue Forecast (FY)$82.81B
Bulls Say, Bears Say
Bulls Say
AI And Digital InitiativesManagement expects artificial intelligence and digital initiatives to enhance merchandising, supply chain, and store operations and to help drive digital profitability excluding retail media.
Price Investments And Private LabelTargeted price investments, expansion of private‑label brands, and cross‑selling between digital and pharmacy are expected to drive unit gains and improve market share in prioritized markets.
ValuationStock trades at a relatively low valuation versus peers, creating potential for valuation expansion as investors rotate into inexpensive, defensive names.
Bears Say
Industry Volume PressureA soft industry backdrop combined with aggressive promotional activity is pressuring unit volumes and weighing on investor sentiment.
Margin CompressionShift toward lower‑margin pharmacy and digital sales, along with incomplete pass‑through of inflation, has compressed gross margins and could limit near‑term profit improvement.
Pharmacy Pricing And RegulationPharmacy pricing changes and government drug‑price negotiation programs are expected to reduce pharmacy sales and represent a notable headwind to top‑line growth.
Albertsons Companies News
ACI FAQ
What was Albertsons Companies’s price range in the past 12 months?
Albertsons Companies lowest stock price was $15.80 and its highest was $22.90 in the past 12 months.
What is Albertsons Companies’s market cap?
Albertsons Companies’s market cap is $8.97B.
When is Albertsons Companies’s upcoming earnings report date?
Albertsons Companies’s upcoming earnings report date is Apr 14, 2026 which is in 10 days.
How were Albertsons Companies’s earnings last quarter?
Albertsons Companies released its earnings results on Jan 07, 2026. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.682 by $0.038.
Is Albertsons Companies overvalued?
According to Wall Street analysts Albertsons Companies’s price is currently Undervalued.
Does Albertsons Companies pay dividends?
Albertsons Companies pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 3.49%. See more information on Albertsons Companies dividends here
What is Albertsons Companies’s EPS estimate?
Albertsons Companies’s EPS estimate is 0.43.
How many shares outstanding does Albertsons Companies have?
Albertsons Companies has 513,913,150 shares outstanding.
What happened to Albertsons Companies’s price movement after its last earnings report?
Albertsons Companies reported an EPS of $0.72 in its last earnings report, beating expectations of $0.682. Following the earnings report the stock price went down -5.961%.
Which hedge fund is a major shareholder of Albertsons Companies?
Currently, no hedge funds are holding shares in ACI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Albertsons Companies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.75 (18.91% Upside)
$20.75 (18.91% Upside)
Blogger Sentiment
Bullish
ACI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $863.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days >0.1%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.65%
12-Months-Change
Fundamentals
Return on Equity
28.54%
Trailing 12-Months
Asset Growth
1.60%
Trailing 12-Months
Company Description
Albertsons Companies
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores. As of February 26, 2022, it operated 2,276 stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and 1,722 pharmacies, 1,317 in-store branded coffee shops, 402 adjacent fuel centers, 22 distribution centers, and 20 manufacturing facilities, as well as various digital platforms. The company was founded in 1860 and is headquartered in Boise, Idaho.
ACI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong execution across digital, pharmacy, loyalty, and productivity initiatives with solid Q3 results (2.4% identical sales growth, 21% digital growth, $1.039B adjusted EBITDA) and clear strategic investments in AI and retail media. Management also outlined disciplined capital allocation and balance-sheet actions. Offsetting these positives are macro-related headwinds (government/SNAP timing), the Medicare drug-price negotiation that creates meaningful top-line headwinds to comparables (noted 65–70 bps in Q4 and modeling risk into 2026), continued industry unit-volume pressure, and near-term gross margin mix impacts. Overall, the positives (accelerating digital and pharmacy growth, loyalty expansion, productivity gains and a clear transformation roadmap) materially outweigh the challenges, though the company flagged notable near-term risks that require monitoring.View all ACI earnings summariesACI Stock 12 Month Forecast
Average Price Target
$20.75
▲(18.91% Upside)
Technical Analysis
Ingles Markets
―
Kroger Company
―
Weis Markets
―
Sprouts Farmers
―
Grocery Outlet Holding
―
Ownership Overview
1.57% Insiders
17.04% Mutual Funds
39.62% Other Institutional Investors
25.70% Public Companies and
Individual Investors